Electronics manufacturing services provider Benchmark (NYSE: BHE) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.2% year on year to $677.3 million. The company expects next quarter’s revenue to be around $720 million, coming in 5.3% above analysts’ estimates. Its non-GAAP profit of $0.58 per share was 4.8% above analysts’ consensus estimates.

Is now the time to buy BHE? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Benchmark’s first quarter results were met with a positive market reaction, reflecting management’s focus on execution and a balanced end-market portfolio. CEO David Moezidis cited accelerating momentum in medical and semi-cap equipment, while the AC&C segment benefited from initial wins in artificial intelligence-related projects. The company’s customer-first initiatives, including disciplined engagements and program prioritization, were credited for more consistent execution. Moezidis also noted, “We saw evidence of improvement across a broad cross-section of our end-markets,” highlighting that bookings activity and operational leverage continued to improve, supported by ongoing working capital efficiency.

Looking ahead, Benchmark’s guidance is underpinned by improving demand signals, especially in semi-cap equipment and AI-related applications. Management expects sequential and year-over-year growth, citing increased capacity from the Penang 4 facility and continued investment in precision technology. Moezidis explained, “We now expect full-year revenue growth to be in the 9% to 10% range, up from our prior expectations of mid-single-digit growth,” emphasizing that EPS growth should outpace revenue due to disciplined expense management and a favorable business mix. The company remains focused on deepening customer engagement and expanding its manufacturing capabilities to support anticipated opportunities.

Key Insights from Management’s Remarks

Management attributed the quarter’s results to broad-based sector gains, operational discipline, and early benefits from AI-related manufacturing wins.

• Medical segment acceleration: The medical business posted substantial year-over-year growth, driven by competitive wins, strong end-market demand, and the launch of new customer programs. Management expects this trend to continue given the breadth of growth drivers in the segment.
• AI-related AC&C ramp: The Advanced Computing & Communications (AC&C) segment experienced significant growth from the ramp-up of artificial intelligence infrastructure projects, particularly those requiring liquid cooling capabilities. These projects are tied to high-performance computing (HPC) and enterprise AI clusters.
• Semi-cap equipment momentum: Semi-capital equipment (Semi-Cap) revenues returned to sequential growth, reflecting both increased share of wallet with existing customers and new customer wins. Investments in capacity, such as the Penang 4 facility, were highlighted as critical to supporting this demand.
• Disciplined operating model: The company’s focus on inventory management and working capital efficiency led to improved cash conversion and higher inventory turns, which management cited as evidence that operational changes are taking hold.
• Bookings consistency: Management reported another quarter of solid bookings, reinforcing confidence in the sustainability of growth and the pacing of sector recoveries, especially as demand signals have strengthened compared to earlier this year.

Drivers of Future Performance

Benchmark’s near-term outlook is shaped by sustained growth in medical, semi-cap, and AI-driven manufacturing, supported by capacity expansion and a disciplined operating approach.

• AI and HPC program ramp: Management expects continued strong growth in AC&C, led by further ramping of AI-related infrastructure and high-performance computing projects. These programs are anticipated to deepen as enterprise adoption of AI clusters expands and new HPC orders materialize later in the year.
• Semi-cap sector recovery: The semi-cap equipment market is projected to deliver mid-teens growth, benefiting from both broader end-market recovery and new manufacturing programs. The Penang 4 facility’s launch is expected to contribute higher margins and increased production capacity.
• Operational and supply chain risks: While management remains confident about sector trends, they acknowledged emerging supply chain challenges, particularly in memory components. Select lead times are starting to increase, underscoring the need for proactive supply chain management to meet rising customer demand.

Catalysts in Upcoming Quarters

In the upcoming quarters, the StockStory team will monitor (1) the ramp and utilization of the Penang 4 facility and its impact on margins, (2) sustained growth and order momentum in AI and high-performance computing infrastructure within AC&C, and (3) the pace of sequential recovery in semi-cap equipment, particularly as new customer programs scale. Continued discipline in supply chain management and inventory efficiency will also be key areas to track.

Benchmark currently trades at $76.44, up from $72.40 just before the earnings. Is there an opportunity in the stock?See for yourself in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.